1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. *Corresponding Author: Ghayas C. Issa, Department of Leukemia, The University of Texas MD Anderson Cancer ...
The Center for Basic Research and Innovation of Medicine and Pharmacy (MOE), School of Pharmacy, Second Military Medical University (Naval Medical University), Shanghai 200433, China ...
State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China Department of Medicinal Chemistry, School ...
The first oral BTK blocker for chronic spontaneous urticaria, Rhapsido offers a more convenient treatment option for patients who still show symptoms after antihistamine treatment. The FDA has ...
Brian Reynolds, 19, (left) and Anthony Constante, 18, (right) face charges of aggravated assault with a deadly weapon, Bexar County court records show. (Bexar County jail) SAN ANTONIO, Texas – Two men ...
Inluriyo is approved for ER-positive, HER2-negative, ESR1-mutated metastatic breast cancer after prior endocrine therapy failure. The EMBER-3 trial showed Inluriyo reduced cancer progression or death ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback